3rd Conf Retro and Opportun Infect. 1996 Jan 28-Feb 1;:172. Unique
Tumor mecrosis factor alpha (TNF-alpha) is produced by monocytes and
macrophages during the host response to infection. Excessive TNF-alpha
production is associated with the symptoms of infection including
fevers, muscle weakness and progressive weight loss. In vitro, TNF-alpha
enhances replication of HIV-1 in latently infected cell lines and in
cells from HIV-1 infected patients. This activation can be inhibited by
the addition of thalidomide which suppresses TNF-alpha production both
in vitro and in vivo. Increased TNF-alpha and soluble TNF-alpha receptor
levels have been reported in the sera of HIV-1 infected patients. We
have shown that in sera of HIV-1 infected patients there is a positive
correlation between TNF-alpha levels and HIV-1 viremia. In HIV-1
infected patients with an opportunistic infection such as
tuberculosis(TB), both TNF-alpha levels and HIV-1 levels were found to
be higher than in patients with HIV-1 infection alone. This relationship
between TNF-alpha level and HIV-1 suggested that a reduction in
TNF-alpha might not only reduce TNF-alpha associated toxicities, but
might also reduce HIV-1 viremia. We have carried out a pilot
double-blind study of thalidomide treatment in patients with HIV-1
associated wasting with or without concomitant TB. Thalidomide therapy
was associated with a reduction in both plasma TNF-alpha levels and
HIV-1 levels in patients dually infected with HIV-1 and TB. A
significant weight gain was observed in HIV-1 infected patients treated
with thalidomide relative to placebo treated patients. Thalidomide is
being investigated for its potential clinical use in reducing TNF-alpha
and HIV-1 levels in patients with HIV-1 and concomitant mycobacterial
infections.
Double-Blind Method HIV Infections/BLOOD/COMPLICATIONS/VIROLOGY
HIV-1/ISOLATION & PURIF/*PHYSIOLOGY Human Macrophages/*METABOLISM
Monocytes/*METABOLISM Pilot Projects Receptors, Tumor Necrosis
Factor/BIOSYNTHESIS Thalidomide/PHARMACOLOGY
Tuberculosis/BLOOD/COMPLICATIONS Tumor Necrosis
Factor/*BIOSYNTHESIS/PHYSIOLOGY Virus Replication/PHYSIOLOGY ABSTRACT
www.aegis.org